Clinical Trials Browser

Phase NA × Lung Neoplasms × salicylhydroxamic acid × Clear all

NCT07272057 2025-12-09

SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes

Phase NA Not yet recruiting

Lung Neoplasms